Combination of interferon alfa 2b and ribavirin in liver transplant recipients with histologic recurrent hepatitis C

被引:0
|
作者
Firpi, RJ [1 ]
Nelson, DR [1 ]
Soldevila, C [1 ]
Abdelmalek, MF [1 ]
Reed, A [1 ]
Hemming, A [1 ]
Howard, R [1 ]
Van der Werk, W [1 ]
Lauwers, G [1 ]
Davis, GL [1 ]
机构
[1] Univ Florida, Gainesville, FL USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
495
引用
收藏
页码:A93 / A93
页数:1
相关论文
共 50 条
  • [1] Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C
    Firpi, RJ
    Abdelmalek, ME
    Soldevila-Pico, C
    Reed, A
    Hemming, A
    Howard, R
    Van der Werf, W
    Lauwers, G
    Liu, C
    Crawford, JM
    Davis, GL
    Nelson, DR
    [J]. LIVER TRANSPLANTATION, 2002, 8 (11) : 1000 - 1006
  • [2] Interferon-alfa2B and ribavirin combination therapy in liver transplant recipients with recurrent hepatitis C.
    Shakil, AO
    Rakela, J
    [J]. HEPATOLOGY, 1999, 30 (04) : 656A - 656A
  • [3] Interferon-alfa2b and ribavirin combination therapy in liver transplant recipients with recurrent hepatitis C.
    Shakil, AO
    McGuire, B
    Crippin, JS
    Canjeevaram, HS
    Teperman, L
    Gish, RG
    Kwo, P
    Wright, TL
    Brass, C
    Balan, V
    Demetris, J
    Rakela, J
    [J]. HEPATOLOGY, 2000, 32 (04) : 216A - 216A
  • [4] A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C
    Shakil, AO
    McGuire, B
    Crippin, J
    Teperman, L
    Demetris, AJ
    Conjeevaram, H
    Gish, R
    Kwo, P
    Balan, V
    Wright, TL
    Brass, C
    Rakela, J
    [J]. HEPATOLOGY, 2002, 36 (05) : 1253 - 1258
  • [5] Treatment with combination peginterferon alfa-2b and ribavirin of recurrent hepatitis C in liver transplant recipients nonresponsive to interferon alfa-2b and ribavirin
    Samanta, A
    Mandalapu, A
    Fisher, A
    Wilson, D
    de la Torre, A
    Klein, KM
    Koneru, B
    [J]. GASTROENTEROLOGY, 2005, 128 (04) : A455 - A456
  • [6] Interferon alfa and ribavirin for orthotopic liver transplant recipients with recurrent hepatitis C.
    Firpi, RJ
    Abdelmalek, MF
    Lauwers, GY
    Nelson, DR
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A1018 - A1018
  • [7] Impact of pegylated interferon alfa-2b and ribavirin on depression in liver transplant recipients with recurrent hepatitis C
    Challis, M
    Rogge, J
    Weaver, L
    Mukherjee, S
    [J]. GASTROENTEROLOGY, 2004, 126 (04) : A699 - A699
  • [8] Treatment of recurrent hepatitis C after liver transplantation with Interferon alfa 2b and Ribavirin
    Zamboni, F
    Franchello, A
    Lavezzo, B
    Strignano, P
    Schellino, M
    Rizzetto, M
    Salizzoni, M
    [J]. TRANSPLANTATION, 2000, 69 (08) : S265 - S265
  • [9] Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapy
    Neff, GW
    Montalbano, M
    O'Brien, CB
    Nishida, S
    Safdar, K
    Bejarano, PA
    Khaled, AS
    Ruiz, P
    Slapak-Green, G
    Lee, M
    Nery, J
    De Medina, M
    Tzakis, A
    Schiff, ER
    [J]. TRANSPLANTATION, 2004, 78 (09) : 1303 - 1307
  • [10] Preliminary treatment results of liver transplant recipients with recurrent hepatitis C virus nonresponsive to interferon alpha2B and ribavirin using combination pegylated interferon alpha 2B with ribavirin.
    Neff, GW
    Montalbano, M
    Lee, YM
    Slapak, G
    Safdar, K
    Morrero, R
    Nery, J
    Weppler, D
    Demodina, M
    Schiff, E
    Tzakis, A
    [J]. HEPATOLOGY, 2002, 36 (04) : 183A - 183A